These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Natural human antibodies to amyloid beta peptide. Szabo P; Relkin N; Weksler ME Autoimmun Rev; 2008 Jun; 7(6):415-20. PubMed ID: 18558354 [TBL] [Abstract][Full Text] [Related]
4. Human monoclonal antibodies against amyloid-beta from healthy adults. Geylis V; Kourilov V; Meiner Z; Nennesmo I; Bogdanovic N; Steinitz M Neurobiol Aging; 2005 May; 26(5):597-606. PubMed ID: 15708434 [TBL] [Abstract][Full Text] [Related]
5. Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Mruthinti S; Buccafusco JJ; Hill WD; Waller JL; Jackson TW; Zamrini EY; Schade RF Neurobiol Aging; 2004 Sep; 25(8):1023-32. PubMed ID: 15212827 [TBL] [Abstract][Full Text] [Related]
6. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses. Chackerian B; Rangel M; Hunter Z; Peabody DS Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604 [TBL] [Abstract][Full Text] [Related]
7. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers. Meli G; Visintin M; Cannistraci I; Cattaneo A J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429 [TBL] [Abstract][Full Text] [Related]
8. A relationship between Alzheimer's disease and type 2 diabetes mellitus through the measurement of serum amyloid-beta autoantibodies. Kim I; Lee J; Hong HJ; Jung ES; Ku YH; Jeong IK; Cho YM; So I; Park KS; Mook-Jung I J Alzheimers Dis; 2010; 19(4):1371-6. PubMed ID: 20061608 [TBL] [Abstract][Full Text] [Related]
9. Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparations. Klaver AC; Finke JM; Digambaranath J; Balasubramaniam M; Loeffler DA Int Immunopharmacol; 2010 Jan; 10(1):115-9. PubMed ID: 19840873 [TBL] [Abstract][Full Text] [Related]
10. Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Abeta quantification following passive immunization with Abeta antibodies. Lanz TA; Schachter JB J Neurosci Methods; 2008 Mar; 169(1):16-22. PubMed ID: 18160105 [TBL] [Abstract][Full Text] [Related]
11. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology. Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies. Geylis V; Steinitz M Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209 [TBL] [Abstract][Full Text] [Related]
13. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898 [TBL] [Abstract][Full Text] [Related]
14. Species-specific immune response to immunization with human versus rodent A beta peptide. Seabrook TJ; Bloom JK; Iglesias M; Spooner ET; Walsh DM; Lemere CA Neurobiol Aging; 2004 Oct; 25(9):1141-51. PubMed ID: 15312960 [TBL] [Abstract][Full Text] [Related]
15. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies. Lee M; Bard F; Johnson-Wood K; Lee C; Hu K; Griffith SG; Black RS; Schenk D; Seubert P Ann Neurol; 2005 Sep; 58(3):430-5. PubMed ID: 16130106 [TBL] [Abstract][Full Text] [Related]
16. Antibody capture of soluble Abeta does not reduce cortical Abeta amyloidosis in the PDAPP mouse. Seubert P; Barbour R; Khan K; Motter R; Tang P; Kholodenko D; Kling K; Schenk D; Johnson-Wood K; Schroeter S; Gill D; Jacobsen JS; Pangalos M; Basi G; Games D Neurodegener Dis; 2008; 5(2):65-71. PubMed ID: 18182780 [TBL] [Abstract][Full Text] [Related]
17. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease. Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612 [TBL] [Abstract][Full Text] [Related]
18. Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease. Dodel R; Hampel H; Depboylu C; Lin S; Gao F; Schock S; Jäckel S; Wei X; Buerger K; Höft C; Hemmer B; Möller HJ; Farlow M; Oertel WH; Sommer N; Du Y Ann Neurol; 2002 Aug; 52(2):253-6. PubMed ID: 12210803 [TBL] [Abstract][Full Text] [Related]
19. Humoral immune responses to peptides derived from the beta-amyloid peptide C-terminal sequence. Miller DL; Potempska A; Mehta PD Amyloid; 2007 Mar; 14(1):39-50. PubMed ID: 17453624 [TBL] [Abstract][Full Text] [Related]